Researcher
Bouke de Jong
Affiliations
- Mycobacteriology (Research unit)
Member
From1 Sep 2010 → Today - Mycobacteriology (Research unit)
Member
From31 Aug 2010 → 16 Apr 2015
Projects
21 - 30 of 75
- EndTB-Q Output 5 testing new regimens to treat MDR-TB resistant to fluoroquinilonesFrom1 Jul 2020 → Today
- MSF Routine ServicesFrom1 Mar 2020 → 28 Feb 2024
- Alternative techniques for monitoring of rifampicin resistant TB treatment response, to replace systematic monitoring by cultureFrom1 Jan 2020 → 31 Dec 2020
- Innovative diagnostic and therapeutic measures to improve MDR-TB diagnosis and management in Conakry, GuineaFrom1 Jan 2020 → Today
- Heteroresistance: an occult threat to the treatment success of resistant tuberculosisFrom1 Jan 2020 → 31 Dec 2023
- Document false rifampicin resistance of Xpert MTB/RIF in Bangladesh and of LPA or MGIT DST in Pakistan, for selected samplesFrom1 Jan 2020 → 31 Dec 2020
- Effectiveness and tolerability of a short regimen for drug resistant tuberculosis treatment in Kandahar Province, Afghanistan, Uncontrolled Clinical StudyFrom1 Sep 2019 → 30 Apr 2022
- Technical assistance and support by the Supranational Reference Laboratory at the Institute of Tropical Medicine in Antwerp (SRL) to the National Reference Laboratory (NRLs) of Georgia and Bangladesh and Proficiency testing for Drug-susceptibility testing (Round 25)From15 May 2019 → 31 May 2020
- Using novel molecular approaches to understand the transmission dynamics of Mycobacterium leprae in the ComorosFrom11 Apr 2019 → Today
- Treatment of Rifampin-resistsant Tuberculosis with an All-Oral Regimen containing new drugs in Zhytomyr UkraineFrom1 Mar 2019 → 31 Jul 2021
Publications
1 - 10 of 172
- The use of Kudoh method for culture of Mycobacterium tuberculosis and Mycobacterium africanum in The Gambia(2024)
Authors: Tijan Jobarteh, J. Otu, Ensa Gitteh, FS Mendy, TI Faal-Jawara, Boatema Ofori-Anyinam, Binta Sarr, Abi Janet Riley, Abigail Ayorinde, Bouke de Jong, et al.
- Refined understanding of the impact of the Mycobacterium tuberculosis complex diversity on the intrinsic susceptibility to pretomanid(2024)
Authors: Rupasinghe Arachchige Praharshinie Rupasinghe, Rabab Reenaers, Jens Vereecken, Leen Rigouts, W Mulders, Stefan Niemann, Matthias Merker, Claudio U. Koeser, Sari Cogneau, Shaheed Vally Omar, et al.
- Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trial(2023)
Authors: Rupasinghe Arachchige Praharshinie Rupasinghe, S. B. Patil, M. Tamirat, K Khazhidinov, Elisa Ardizzoni, M. Atger, A Austin, E. Baudin, M Bekhit, S Bektasov, et al.
- Rifampicin resistance conferring mutations among Mycobacterium tuberculosis strains in Rwanda(2023)
Authors: Isabel Cuella Martin, Jean Claude Semuto Ngabonziza, Gabriela Torrea, Conor J. Meehan, W Mulders, Bertin Ushizimpumu, Louise De Weerdt, Jelle Keysers, Willem Bram de Rijk, T Decroo, et al.
Pages: 274-281 - Protocol, rationale and design of BE-PEOPLE (Bedaquiline enhanced exposure prophylaxis for LEprosy in the Comoros): a cluster randomized trial on effectiveness of rifampicin and bedaquiline as post-exposure prophylaxis of leprosy contacts(2023)
Authors: Assoumani Younoussa, Said Nourdine Samidine, Auke T Bergeman, Alberto Piubello, Nissad Attoumani, Silahi Halifa Grillone, Sofie Braet, Achilleas Tsoumanis, Abdallah Baco, Aboubacar Mzembaba, et al.
Pages: 310 - Community-supported self-administered tuberculosis treatment combined with active tuberculosis screening: a pilot experience in Conakry, Guinea(2023)
Authors: Souleymane Hassane-Harouna, Tinne Gils, T Decroo, Nimer Ortuno-Gutierrez, Alexandre Delamou, Gba-Foromo Cherif, Lansana Mady Camara, Leen Rigouts, Bouke de Jong
- Hi-plex deep amplicon sequencing for identification, high-resolution genotyping and multidrug resistance prediction of Mycobacterium leprae directly from patient biopsies by using Deeplex Myc-Lep(2023)
Authors: Agathe Jouet, Sofie Braet, Cyril Gaudin, G Bisch, Sidra Ezidio Gonçalves Vasconcellos, REEND do Livramento, YYP Palacios, Amanda B. Fontes, N. Lucena-Silva, Patricia S. Rosa, et al.
- Borderline rpoB mutations transmit at the same rate as common rpoB mutations in a tuberculosis cohort in Bangladesh(2023)
Authors: Pauline Lempens, Armand Van Deun, Kya J M Aung, Mohammad A Hossain, Mahboobeh Behruznia, T Decroo, Leen Rigouts, Bouke de Jong, Conor J. Meehan
- Mycobacterium tuberculosis retains viability in RNAlater buffer but not in GTC-TCEP and DNA/RNA Shield(2023)
Authors: Lena Krausser, Sofie Braet, Z Benaamar, Magalie Van Dyck-Lippens, Bouke de Jong, Leen Rigouts
Pages: 115905 - GeneXpert MTB/RIF Ultra performance to detect uncommon rpoB mutations in Mycobacterium tuberculosis(2023)
Authors: Leen Rigouts, Jelle Keysers, Rabab Reenaers, K Fissette, Armand Van Deun, Bouke de Jong